3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Colorectal Neoplasms
12
Breast Neoplasms
11
Lung Neoplasms
9
Uterine Cervical Neoplasms
8
Neoplasms
8
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Colorectal Cancer Screening
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Head and Neck Neoplasms
1
Interventions
Cholecalciferol
4
Nutrition Assessment
3
Exercise
3
Blood Pressure
3
Atorvastatin
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Vitamin E
2
Vitamin D
2
Rosuvastatin Calcium
2
Methods
2
Metformin
2
Gonadotropin-Releasing Hormone
2
Geritol
2
Fish Oils
2
Fatty Acids, Omega-3
2
Ethanol
2
Educational Status
2
Diet, Mediterranean
2
Aspirin
2
xinmailong
1
sofosbuvir-velpatasvir drug combination
1
pembrolizumab
1
palbociclib
1
ficlatuzumab
1
beta Carotene
1
amlodipine, atorvastatin drug combination
1
Vorinostat
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cardiovascular Diseases
×
Patient Navigation
×
Clear all
NCT06648278
2026-01-13
COUNTS2
University of California, San Francisco
Phase NA
Recruiting
260 enrolled